Patents by Inventor Vimla Band

Vimla Band has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20190374578
    Abstract: Methods and compositions for treating cancer, particularly improved CAR-T methods, are disclosed.
    Type: Application
    Filed: February 23, 2018
    Publication date: December 12, 2019
    Inventors: Hamid Band, Vimla Band, Fany Iseka, Bhopal Mohapatra, Matthew Storck
  • Cancer biomarkers and methods of use thereof
    Patent number: 9850313
    Abstract: Methods and compositions for treating cancer, particularly breast cancer, are disclosed.
    Type: Grant
    Filed: August 5, 2013
    Date of Patent: December 26, 2017
    Assignee: Board of Regents of the University of Nebraska
    Inventors: Vimla Band, Hamid Band, Sameer Mirza
  • Cancer Biomarkers and Methods of Use Thereof
    Publication number: 20150203588
    Abstract: Methods and compositions for treating cancer, particularly breast cancer, are disclosed.
    Type: Application
    Filed: August 5, 2013
    Publication date: July 23, 2015
    Inventors: Vimla Band, Hamid Band, Sameer Mirza
  • NES-1 polypeptides, DNA, and related molecules and methods
    Publication number: 20060099630
    Abstract: Disclosed is substantially pure NES1 polypeptide and purified DNA, vectors, and cells encoding that polypeptide. Also disclosed are methods for carcinoma detection and treatment using the NES1 sequence.
    Type: Application
    Filed: November 30, 2005
    Publication date: May 11, 2006
    Inventor: Vimla Band
  • NES-1 polypeptides, DNA, and related molecules and methods
    Patent number: 7033746
    Abstract: Disclosed is substantially pure NES1 polypeptide and purified DNA, vectors, and cells encoding that polypeptide. Also disclosed are methods for carcinoma detection and treatment using the NES1 sequence.
    Type: Grant
    Filed: December 12, 2001
    Date of Patent: April 25, 2006
    Assignee: New England Medical Center Hospitals, Inc.
    Inventor: Vimla Band
  • Novel E6 targeted protein (E6TP1)
    Publication number: 20030064477
    Abstract: The invention relates to a putative human tumor suppressor protein identified as a novel GAP protein, designated “E6TP1” (for E6-targeted protein), its nucleic acid and amino acid sequences, and methods of use thereof in the regulation of small G protein signaling pathways. In addition, methods of use of E6TP1 as a Therapeutic for treatment or prevention of carcinomas, especially HPV-associated carcinomas of anogenital origin, and other diseases is encompassed in the invention.
    Type: Application
    Filed: August 8, 2002
    Publication date: April 3, 2003
    Inventors: Vimla Band, Qingshen Gao
  • E6 targeted protein (E6TP1)
    Patent number: 6440696
    Abstract: The invention relates to a putative human tumor suppressor protein identified as a novel GAP protein, designated “E6TP1” (for E6-targeted protein), its nucleic acid and amino acid sequences, and methods of use thereof in the regulation of small G protein signaling pathways. In addition, methods of use of E6TP1 as a Therapeutic for treatment or prevention of carcinomas, especially HPV-associated carcinomas of anogenital origin, and other diseases is encompassed in the invention.
    Type: Grant
    Filed: July 28, 1999
    Date of Patent: August 27, 2002
    Assignee: New England Medical Center
    Inventors: Vimla Band, Qingshen Gao
  • NES-1 polypeptides, DNA, and related molecules and methods
    Publication number: 20020106367
    Abstract: Disclosed is substantially pure NES1 polypeptide and purified DNA, vectors, and cells encoding that polypeptide. Also disclosed are methods for carcinoma detection and treatment using the NES1 sequence.
    Type: Application
    Filed: December 12, 2001
    Publication date: August 8, 2002
    Applicant: New England Medical Center Hospitals, Inc., Massachusetts corporation
    Inventor: Vimla Band
  • NES-1 polypeptides, DNA, and related molecules and methods
    Patent number: 6153387
    Abstract: Disclosed is substantially pure NES1 polypeptide and purified DNA, vectors, and cells encoding that polypeptide. Also disclosed are methods for carcinoma detection and treatment using the NES1 sequence.
    Type: Grant
    Filed: November 30, 1998
    Date of Patent: November 28, 2000
    Assignee: New England Medical Center Hospitals, Inc.
    Inventor: Vimla Band
  • Methods for identification of modulatory compounds for the expression of the NES1 protein
    Patent number: 5843694
    Abstract: The expression and purification of normal epithelial specific polypeptide (NES 1) which is expressed in normal cells, but not in radiation transformed cells, are described. Both the DNA sequence encoding the NES1 and the corresponding amino acid sequence are disclosed. Also, disclosed are methods for carcinoma detection and treatment using the NES1 as well as methods of identifying compounds modulating the expression and activity of NES1.
    Type: Grant
    Filed: April 5, 1996
    Date of Patent: December 1, 1998
    Assignee: New England Medical Center Hospitals, Inc.
    Inventor: Vimla Band
  • NES-1 polypeptides, DNA, and related molecules and methods
    Patent number: 5736377
    Abstract: The expression and purification of normal epithelial specific polypeptide (NES1) which is expressed in normal cells, but not in radiation transformed cells, are described. Both the DNA sequence encoding the NES1 and the corresponding amino acid sequence are disclosed. Also, disclosed are methods for carcinoma detection and treatment using the NES1 as well as methods of identifying compounds modulating the expression and activity of NES1.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: April 7, 1998
    Assignee: New England Medical Center Hospitals, Inc.
    Inventor: Vimla Band